Spok Holdings, Inc.

NASDAQ:SPOK

Medical - Healthcare Information Services

Healthcare
$10.93 +1.60%

+$0.17 today

Market cap
$228.30M
Beta
0.44
P/E (TTM)
17.2
EPS (TTM)
$0.61
Dividend yield
11.93%
52W Low $9.95High $19.31

Volume 0.18M

Average 0.17M

SPOK Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Spok Holdings, Inc.NASDAQ: SPOK

Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Financing cash flow declines year over year

Q1 FY2026 financing cash flow of $10.03M (cash outflow) fell 7.0% year over year, behind the -1.6% change in trailing-twelve-month financing cash flow. Sequentially, it rose 61.1% from the prior quarter. Over 3 fiscal years it compounded at +4.3% a year.

Context

  • Financing cash flow amounted to 21.3% of revenue in FY2025, up 0.6 pp from a year earlier.
  • Financing cash flow grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -7.0% toward the trailing-twelve-month pace of -1.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$10.03M+61.1% QoQ
Last fiscal yearDec 2025
-$29.79M+4.4% YoY
LTMMar 2026
-$29.03M-1.6% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-7.0%——
1 year+4.4%——
3-year CAGR+4.3%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
(29.79M) USD
Year-over-year change
-4.4%

Financing Cash Flow vs competitors

How SPOK compares with its peers on the latest reported figures

  • Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -1.6% is the 7th highest of 11, against a peer median of +98.6%.
  • Financing cash flow amounts to 21.2% of revenue for SPOK, versus a peer median of 8.5%.
SPOK Competitors
Financing Cash Flow for SPOK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CGCCanopy Growth CorporationLTM Mar 2026CA$366.4M CAD+146.5%—117.3%
SENSSenseonics Holdings, Inc.LTM Mar 2026$75.48M USD+229.4%+23.2%185.4%
DHDefinitive Healthcare Corp.LTM Mar 2026$51.96M USD-65.2%+78.1%21.8%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$46.34M USD+308.7%—57.1%
SPOKSpok Holdings, Inc.LTM Mar 2026$29.03M USD-1.6%+4.3%21.2%
NRCNational Research CorporationLTM Mar 2026$17.39M USD+86.9%-34.2%12.5%
VMDViemed Healthcare, Inc.LTM Mar 2026$10.41M USD+156.8%-27.6%3.6%
TBRGTruBridge, Inc.LTM Mar 2026$6.15M USD-68.3%—1.8%
MASS908 Devices Inc.LTM Mar 2026$2.56M USD-450.0%—4.4%
SLPSimulations Plus, Inc.LTM Feb 2026$590K USD+110.3%-46.8%0.7%
CERSCerus CorporationLTM Mar 2026$352K USD-25.7%+5.8%0.2%
Peer median (excluding SPOK) —+98.6%-10.9%8.5%

Competitors are the stored peer set for SPOK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(22.18M)21.86M15.67M14.97M15.88M
Depreciation & Amortization10.45M3.57M4.5M4.15M3.43M
Deferred Income Tax(5.48M)903K6.38M4.57M5.17M
Stock-Based Compensation7.24M3.83M4.06M4.96M5.01M
Change in Working Capital1.12M(3.63M)(5.37M)(566K)(966K)
Accounts Receivables1.83M(1.76M)2.58M506K(1.96M)
Inventory3.36M0000
Accounts Payables(679K)(2.26M)(5.22M)(1.18M)(1.74M)
Other Working Capital(3.39M)387K(2.73M)112K2.73M
Other Non-Cash Items16.83M(20.07M)950K846K430K
Operating Cash Flow7.97M6.46M26.18M28.92M28.95M
Capital Expenditures(15.24M)(3.78M)(3.42M)(3.21M)(3.75M)
Acquisitions (Net)10.84M(15.03M)000
Purchases of Investments(44.99M)(14.97M)000
Sales of Investments60M30M000
Other Investing Activities(10.84M)15.03M00701K
Investing Cash Flow(225K)11.26M(3.42M)(3.21M)(3.05M)
Debt Repayment00000
Common Stock Issued0000312K
Common Stock Repurchased(1.86M)(1.21M)(1.25M)(2.43M)(2.84M)
Dividends Paid(10.03M)(25.01M)(25.64M)(26.38M)(27.26M)
Other Financing Activities132K0210K272K0
Financing Cash Flow(11.75M)(26.22M)(26.68M)(28.54M)(29.79M)
Effect of Forex Changes(136K)(321K)145K(20K)28K
Net Change in Cash(4.15M)(8.83M)(3.77M)(2.84M)(3.87M)
Free Cash Flow(7.27M)2.68M22.77M25.71M25.2M

Spok Holdings, Inc.

NASDAQ:SPOK

Intrinsic Alpha fair value

Locked

Current Price

$10.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.